AltaScience has carried out
clinical trials with AltaSeal® in
Ireland and The Netherlands. Patients recruited to the trials have had the
AltaSeal® implants placed as an outpatient procedure without the
need for general anaesthetic. The clinical trials have covered it's use as a sterilisation device. In addition the device has been used to occlude fallopian
tubes in patients with hydrosalpinges who have had previous failed IVF therapy with excellent clinical results.
The development of AltaSeal®
was recently reported in a peer reviewed journal, the article is titled Development and Initial Clinical Experience
with AltaSeal®: A Novel Hysterscopically Placed Permanent
Contraception System. (See below). The paper concludes that’s to date
can efficiently occlude fallopian tubes for both prevention of
pregnancy and possibly return the rate of successful IVF treatments in patients with
hydrosalpinges to levels seen in patients without hydrosalpinges.
THIS DEVICE IS NOT YET FOR SALE IN THE UNITED STATES
– IT IS AN INVESTIGATIONAL DEVICE LIMITED BY FEDERAL (OR UNITED STATES) LAW TO INVESTIGATIONAL USE.